Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerosis, Progressive Systemic”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Testing effectiveness (Phase 2)Ended earlyNCT04781543
What this trial is testing

Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 301
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287670
What this trial is testing

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Mediar Therapeutics 85
Not applicableUnknownNCT01785056
What this trial is testing

IVIG Treatment in Systemic Sclerosis

Who this might be right for
Systemic SclerosisDiffuse Scleroderma
Georgetown University 14
Testing effectiveness (Phase 2)Looking for participantsNCT06655896
What this trial is testing

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Novartis Pharmaceuticals 96
Testing effectiveness (Phase 2)Study completedNCT02921971
What this trial is testing

Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 97
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)WithdrawnNCT04138485
What this trial is testing

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring
Testing effectiveness (Phase 2)Ended earlyNCT03919799
What this trial is testing

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
System; SclerosisDiffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 36
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Testing effectiveness (Phase 2)Study completedNCT04440592
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Tanabe Pharma America, Inc. 76
Early research (Phase 1)Looking for participantsNCT06647069
What this trial is testing

DR-0201 in Subjects With Autoimmune Diseases

Who this might be right for
SLESLE (Systemic Lupus)CLE+9 more
Dren Bio 36
Not applicableLooking for participantsNCT07000916
What this trial is testing

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic ArthritisRheumatoid ArthritisPsoriatic Arthritis+3 more
Université Catholique de Louvain 1,000
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Study completedNCT02370784
What this trial is testing

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Who this might be right for
Scleroderma
Robyn T. Domsic, MD, MPH 24
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Not applicableWithdrawnNCT02531009
What this trial is testing

Systemic Sclerosis Clinical and Biomarker Study

Who this might be right for
HealthySystemic Sclerosis
Biogen
Early research (Phase 1)Study completedNCT03831438
What this trial is testing

Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Bristol-Myers Squibb 9
Load More Results